NCT02056496 - Pharmacokinetics and Bioavailability of Pomegranate Phenolics and Urolithins in Healthy Subjects. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2014

Study Completion Date

February 28, 2014

Conditions

Healthy

Interventions

DIETARY_SUPPLEMENT

Pomegranate extract

Crossover study: The group will consume the pomegranate extract with low punicalagin:EA ratio (PE-1). After 2 weeks of washout, the same group will also consume the other extract with high punicalagin: EA ratio (PE-2).

DIETARY_SUPPLEMENT

Pomegranate extract

Crossover study: The group will consume the pomegranate extract with high punicalagin:EA ratio (PE-2) after 2 weeks of washout. The same group will also consume the other extract with low punicalagin: EA ratio (PE-1).

Trial Locations (1)

30107

UCAM (San Antonio Catholic University from Murcia), Murcia